GMP News and Research

RSS

Mycoplasma in Cell Culture: Fighting Back with Rapid Detection Kits

In this interview, discussing the effects of mycoplasma contamination on cell cultures and the development of rapid detection kits that provide answers in just thirty minutes.

From Gold Biotechnology, Inc. 24 Jan 2020

Synthego adopts good manufacturing practices for highest-quality genome engineering for clinical applications

Synthego, the genome engineering company, today announced it has adopted Good Manufacturing Practice standards to provide academic and industry partners with high-quality reagents for use in clinical research and development.

From Synthego Corporation 23 Jan 2020

Synthego adopts GMP standards for producing sgRNA

Synthego has adopted Good Manufacturing Practice standards for producing customized GMP-grade synthetic guide RNA at its facilities, an initiative the company said will benefit its academic and industry customers as they develop advanced cell and gene therapies.

From Synthego Corporation 23 Jan 2020

New approach for the manufacture of Advanced Therapy Medicinal Products

Akron Biotechnology has proposed a new approach for the qualification of ancillary materials for the manufacture of Advanced Therapy Medicinal Products.

22 Jan 2020

Control and Monitor Nanoparticle, Biopharmaceutical and Polymer Product Process

In this interview, Jason Lin, Application Scientist from Wyatt Technology, talks to News-Medical about the new ultraDAWN that is a breakthrough in monitoring nanoparticle biopharmaceutical and polymer product process.

From Waters | Wyatt Technology 10 Dec 2019

Polyplus-transfection expands GMP portfolio to provide additional flexibility for gene and cell therapy developers

Polyplus-transfection(R) SA, the leading biotechnology company that supports gene and cell therapy by supplying innovative transfection solutions, today announces the availability of the first GMP-grade transfection reagent PEIpro(R)-GMP in additional conditioning that will ensure additional flexibility and cost-efficiency.

From Polyplus-transfection 6 Dec 2019

New partnership aims to explore, cultivate innovations in cell and gene therapy

Some patients who have not responded to traditional medicines are now experiencing remarkable recoveries thanks to next-generation immunotherapies. These therapies equip a patient's own immune cells to recognize, target, and destroy cancer cells.

25 Nov 2019

National effort to develop implantable bio-artificial kidney achieves key milestone

The Kidney Project, a national effort to develop an implantable bio-artificial kidney that could eliminate the need for dialysis, will announce a key milestone in a November 7, 2019 presentation at the American Society of Nephrology Kidney Week 2019 conference in Washington, DC.

7 Nov 2019

Cherwell to showcase new ImpactAir ISO-90 microbial air sampler at Pharmig

Cherwell Laboratories, specialist suppliers of environmental monitoring and process validation solutions for the pharmaceutical and related industries, will once again be supporting Pharmig’s Annual Conference.

From Cherwell Laboratories 30 Oct 2019

Pepscan announces increased GMP production capacity to facilitate clients' growth

Today, Pepscan announced that its GMP production capacity has doubled. Pepscan is an all-in-one partner in peptides, building on 25 years of experience in advancing and applying peptide expertise to facilitate clients in the development and production of peptides.

9 Oct 2019

Lonza and Nephron to present results of MODA-ES Platform implementation at 2019 ISPE Meeting & Expo

During the 2019 ISPE Meeting & Expo (27–30 October, Las Vegas, Nevada), Lonza and Nephron Pharmaceuticals Corporation will co-present the results of the first implementation of Lonza’s MODA-ES Platform, a next-generation electronic batch record solution for the pharmaceutical manufacturing industry.

From Lonza 4 Oct 2019

Duke Human Vaccine Institute participates in a large national effort to improve flu shots

As part of a massive national effort to improve and modernize flu shots, the Duke Human Vaccine Institute has received three research contracts from the National Institute of Allergy and Infectious Diseases, with an initial award of approximately $29.6 million in first-year funding.

30 Sep 2019

Discovery of combination protein leads to first-in-human clinical trial for leukemia

The discovery of tri-specific natural killer engagers (TriKE™), a combination protein that bridges an immune cell and a tumor cell to drive tumor cell killing power exponentially, has led to a new Phase I, first-in-human study to treat leukemia.

20 Sep 2019

Tecan to launch Fluent Gx Automation Workstation for use in regulated laboratories

Tecan’s range of advanced liquid handling solutions will soon be enhanced with the introduction of the new Fluent® Gx Automation Workstation, designed specifically to meet the stringent needs of clinical and regulated laboratories.

From Tecan 29 Aug 2019

Virginia Tech professor wins NSF grant to study biofilm formation in bacteria

Should I stay or should I go? This is a common question people ask themselves in their journey through life, but bacteria are also asking the same question.

22 Aug 2019

Sartorius Stedim Biotech announces launch of new services for mammalian cell bank manufacturing

Sartorius Stedim Biotech (SSB), a leading partner of the biopharmaceutical industry, today announced the launch of new services for mammalian cell bank manufacture under GMP conditions.

From Sartorius 13 Aug 2019

Family Doctors play key role in imparting health education on advanced therapies

A recent study conducted jointly by the Tissue Engineering Research Group of the Department of Histology and the Family Medicine Unit of the University of Granada has highlighted the conceptual, attitudinal, and procedural profile of resident hospital doctors specializing in Family Medicine, in relation to the so-called advanced therapies.

25 Jun 2019

Lean manufacturing methods spur innovations in the testing of drug delivery devices

The number of people who live with diabetes is on the rise. By estimates of the World Health Organization (WHO), one in eleven people are affected by the disease.

21 Jun 2019

Research could lead to new treatments for people with autoimmune disorders

The immune system is programmed to rid the body of biological bad guys--like viruses and dangerous bacteria--but its precision isn't guaranteed. In the tens of millions of Americans suffering from autoimmune diseases, the system mistakes normal cells for malicious invaders, prompting the body to engage in self-destructive behavior.

29 May 2019

Merck to collaborate with GenScript for plasmid and virus manufacturing in China

Merck, a leading science and technology company, today announced the signing of a non-binding Memorandum of Understanding with Chinese biotech company GenScript for a strategic alliance focusing on plasmid and viral vector manufacturing.

From Merck 20 Mar 2019